DEAR DR. GOTT: You told a reader the injectable form of colchicine is no longer available but the oral tablet is. I beg to differ. I recently attempted to get a renewal of colchicine and was told by ...

PHILADELPHIA, March 31 A newly-published clinical study demonstrates that Colcrys® (colchicine, USP), a low-dose oral colchicine, is just as effective as high-dose colchicine in reducing pain ...

Dear Dr. Gott: You told a reader the injectable form of colchicine is no longer available but the oral tablet is. I beg to differ. I recently attempted to get a renewal of colchicine and was told by ...

Analysis of Pivotal AGREE Trial Finds No Correlation Between Incidence of Adverse Events and Age, Disease Duration or Gout-Related Comorbidities ATLANTA, Nov. 8, 2010 /PRNewswire/ -- Patients who ...

Q: You told a reader the injectable form of colchicine is no longer available but the oral tablet is. I beg to differ. I recently attempted to get a renewal of colchicine and was told by the ...

Please provide your email address to receive an email when new articles are posted on . The approval of Colcrys in July 2009 and its market exclusivity that followed created higher costs and reduced ...

PHILADELPHIA – New data show that low-dose colchicine (Colcrys TM) rapidly controls acute gout flares. The results, which were presented at the 2009 Annual Scientific Meeting of the American College ...

Please provide your email address to receive an email when new articles are posted on . Although the FDA-mandated exclusivity of colchicine ended and generics were introduced to the market, prices ...

A so-called authorized generic version of the colchicine formulation sold as Colcrys for acute gout flares and for treating familial Mediterranean fever will be "widely available" starting later this ...

URL Pharma, Inc., today announced that the FDA has issued new label information affecting all approved protease inhibitors for treatment of HIV when co-administered with Colcrys (colchicine). These ...

The FDA has approved Colcrys (colchicine tablets, from AR Scientific), a single-ingredient oral colchicine product, for the treatment of familial Mediterranean fever (FMF) in patients ≥4 years of age ...